Yu Fen-Fen, Chen Li-Li, Su Yi-Hua, Huo Li-Hun, Lin Xian-Xuan, Liao Rui-Duan
Department of Ophthalmology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China.
Department of Pathology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China.
Int J Ophthalmol. 2015 Dec 18;8(6):1224-8. doi: 10.3980/j.issn.2222-3959.2015.06.27. eCollection 2015.
To investigate the influencing factors of visual field improvement after trans-sphenoidal resection of pituitary macroadenomas.
This retrospective cohort study included 201 patients (366 eyes) with visual field defect induced by pituitary macroadenomas. All of them were treated with trans-sphenoidal surgery. Ophthalmologic evaluation, best-corrected visual acuity (BCVA), and visual field examination were performed before and 3mo after surgery. BCVA, visual field defect index mean deviation (MD), duration of symptoms, age, sex, and volume of tumors were compared. Expression of vascular endothelial growth factor (VEGF) and Ki-67 of tumor tissue were detected by immunohistochemical technique.
The mean age of patients was 44.23±1.29y. Ninety-three patients were female and 108 were male. The mean tumor volume was 14.36±6.23 cm(3). The mean duration of preoperative symptoms was 11.50±0.88mo. Mean preoperative MD was -17.50±0.82 dB. Mean Preoperative visual acuity was 0.64±0.04. Postoperative visual field improved in 270 (73.77%) eyes, unchanged in 96 (26.23%) eyes. Multivariate logistic regression displayed that the factors independently influencing visual field improvement were young age (OR=1.71, 95%CI: 1.325-2.387, P=0.013), low preoperative MD absolute value (OR=1.277, 95%CI: 1.205-1.355, P<0.001), small volume of tumor (OR=1.458, 95%CI: 1.060-4.289, P<0.001), low expression of VEGF in tumor tissue (OR=1.554, 95%CI: 1.089-2.457, P=0.022), and low expression of Ki-67 in tumor tissue (OR=1.552, 95%CI: 1.161-2.847, P=0.026).
After pituitary macroadenomas trans-sphenoidal resection, the independent influencing factors of the visual fields recovery were low preoperative MD absolute value, young age, small volume of tumor, and expression levels of VEGF/ Ki-67.
探讨经蝶窦切除垂体大腺瘤后视野改善的影响因素。
这项回顾性队列研究纳入了201例(366只眼)因垂体大腺瘤导致视野缺损的患者。所有患者均接受经蝶窦手术治疗。在手术前及术后3个月进行眼科评估、最佳矫正视力(BCVA)和视野检查。比较BCVA、视野缺损指数平均偏差(MD)、症状持续时间、年龄、性别和肿瘤体积。采用免疫组织化学技术检测肿瘤组织中血管内皮生长因子(VEGF)和Ki-67的表达。
患者的平均年龄为44.23±1.29岁。女性93例,男性108例。平均肿瘤体积为14.36±6.23 cm³。术前症状的平均持续时间为11.50±0.88个月。术前平均MD为-17.50±0.82 dB。术前平均视力为0.64±0.04。术后270只眼(73.77%)视野改善,96只眼(26.23%)视野无变化。多因素logistic回归显示,独立影响视野改善的因素为年轻(OR=1.71,95%CI:1.325-2.387,P=0.013)、术前MD绝对值低(OR=1.277,95%CI:1.205-1.355,P<0.001)、肿瘤体积小(OR=1.458,95%CI:1.060-4.289,P<0.001)、肿瘤组织中VEGF低表达(OR=1.554,95%CI:1.089-2.457,P=0.022)和肿瘤组织中Ki-67低表达(OR=1.552,95%CI:1.161-2.847,P=0.026)。
经蝶窦切除垂体大腺瘤后,视野恢复的独立影响因素为术前MD绝对值低、年轻、肿瘤体积小以及VEGF/Ki-67的表达水平。